GAP Investment Advisory Board and Committee
Composed of leading members of Virginia's early-stage investment community, CIT's Investment Advisory Board (IAB) and Investment Committee guides CIT in making all GAP Program investment decisions.
Daniel Barchi
President and CEO, Carilion Biomedical Institute
Investment Advisory Board – August 2006 to Present
GAP BioLife Investment Committee Member
Wagish
Bhartiya
Associate,
Grotech Capital
Investment
Advisory Board – November
2007 to Present
GAP
Tech Investment
Committee Member
William Caragol
Chief Financial Officer, Government Telecommunications, Inc.
Investment Advisory Board – November 2003 to September 2006
Charles Curran
General Partner, Valhalla Partners
Investment Advisory Board – August 2006 to May 2007
Hiram Ewald
Managing Partner, Tall Oaks Capital
Investment Advisory Board – August 2006 to Present
GAP BioLife Investment Committee Member
Tom Grossi
Principal, New Enterprise Associates (NEA)
Investment Advisory Board – August 2006 to Present
GAP Tech Investment Committee Member
Peter Jobse
President and CEO, Center for Innovative Technology
Investment Advisory Board – November 2003 to Present
GAP Tech Investment Committee Member & GAP BioLife Investment Committee Member
Suzanne King
Partner, New Enterprise Associates
Investment Advisory Board – November 2003 to June 2006
Eric Koefoot
Investment Advisory Board – January 2008 to Present
GAP Tech Investment Committee Member
John May
Managing Partner, New Vantage Group
Investment Advisory Board – November 2003 to May 2007
Don Rainey
Partner, Intersouth Venture Partners
Investment Advisory Board – November 2003 to May 2007
Dr. Bruce Robertson
Managing Director, H.I.G Ventures
Investment Advisory Board – November 2003 to Present
GAP BioLife Investment Committee Member
Jill Stelfox
Co-founder, Chairman, CEO, Defywire
Investment Advisory Board – November 2003 to December 2007
GAP Tech Investment Committee Member
John Uhrin
Venture Partner, Harbert Management Corporation
Investment Advisory Board – January 2008 to Present
GAP BioLife Investment Committee Member
S. Tien Wong
Chief Executive Officer, Opus8
Investment Advisory Board – August 2006 to Present
GAP Tech Investment Committee Member
